In 3-5 years, Piramal Pharma can see 22- 25% EBITDA growth margins: Nandini Piramal

May 14, 2024

Nandini Piramal projects early teens revenue growth for FY25 and 22-25% EBITDA growth margins in 3-5 years. Revenue increase drives margin expansion through cost optimization and operational excellence, with a focus on CDMO and Indian consumer products growth.

More To Explore

Berkshire Hathaway CEO Greg Abel sees AI, power demand as new engines of growth

Berkshire Hathaway sees AI opportunities beyond technology stocks. The company is investing in Alphabet, a significant player in artificial intelligence. Berkshire Hathaway Energy could benefit

September 2, 2026

Multibaggers: These 9 midcap stocks surged up to 300% in two years. Do you own any?

While the Nifty 50 declined nearly 5% over the past two years and the Nifty Midcap 150 gained around 6%, select midcap stocks delivered exceptional

September 2, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003